MOORE CAPITAL MANAGEMENT, LP - EUROPEAN BIOTECH ACQUTN CORP ownership

EUROPEAN BIOTECH ACQUTN CORP's ticker is EBACW and the CUSIP is G3167F128. A total of 35 filers reported holding EUROPEAN BIOTECH ACQUTN CORP in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
MOORE CAPITAL MANAGEMENT, LP ownership history of EUROPEAN BIOTECH ACQUTN CORP
ValueSharesWeighting
Q4 2022$10,417
+160.4%
41,6660.0%0.00%
Q3 2022$4,000
-33.3%
41,6660.0%0.00%
Q2 2022$6,000
-25.0%
41,6660.0%0.00%
Q1 2022$8,000
-68.0%
41,6660.0%0.00%
Q4 2021$25,000
+4.2%
41,6660.0%0.00%
Q3 2021$24,000
-40.0%
41,6660.0%0.00%
-100.0%
Q2 2021$40,00041,6660.00%
Other shareholders
EUROPEAN BIOTECH ACQUTN CORP shareholders Q4 2022
NameSharesValueWeighting ↓
Athanor Capital, LP 39,251$380,0000.05%
Radcliffe Capital Management, L.P. 66,666$649,0000.02%
Arena Capital Advisors, LLC- CA 100,299$62,0000.01%
Exos Asset Management LLC 15,100$9,0000.01%
MARSHALL WACE, LLP 108,584$1,057,0000.00%
MMCAP International Inc. SPC 77,425$48,0000.00%
GABELLI & Co INVESTMENT ADVISERS, INC. 21,896$14,0000.00%
Atalaya Capital Management LP 13,333$8,0000.00%
SUVRETTA CAPITAL MANAGEMENT, LLC 100,000$62,0000.00%
FIR TREE CAPITAL MANAGEMENT LP 49,997$29,0000.00%
View complete list of EUROPEAN BIOTECH ACQUTN CORP shareholders